Clinical Trial Update: FOLFIRINOX + RT for Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFIRINOX combined with radiotherapy for pancreatic cancer; results date not provided in snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX + RT

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN | Results posted: 2018-04-30